Literature DB >> 12972116

Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease.

Thor Ueland1, Liv I Sikkeland, Arne Yndestad, Hans G Eiken, Torbjørn Holm, Cecilia Guevara, Terje Haug, Knut Endresen, Stig S Frøland, Lars Gullestad, Arne K Andreassen, Odd Geiran, Svein Simonsen, Pål Aukrust.   

Abstract

Long-term success of cardiac transplantation is mainly limited by the development of transplant coronary artery disease (CAD); it is generally accepted that it is immune mediated, involving cytokines and growth factors. We show that development of transplant CAD is associated with a particular cytokine profile in myocardial biopsies characterized by a late (i.e., 1 year) increase in tumor necrosis factor-alpha and interferon-gamma gene expression, which precede and potentially contribute to the development of allograft vasculopathy, further supporting a role for inflammation and the pathogenesis of transplant CAD in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972116     DOI: 10.1016/s0002-9149(03)00836-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.

Authors:  A Heidland; K Sebeková; A Frangiosa; L S De Santo; M Cirillo; F Rossi; M Cotrufo; A Perna; A Klassen; R Schinzel; N G De Santo
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

2.  IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells.

Authors:  Beatrice Bolinger; Daniel Engeler; Philippe Krebs; Simone Miller; Sonja Firner; Matthias Hoffmann; Douglas C Palmer; Nicholas P Restifo; Yinghua Tian; Pierre-Alain Clavien; Burkhard Ludewig
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.